Literature DB >> 23536288

Mining the antibodyome for HIV-1-neutralizing antibodies with next-generation sequencing and phylogenetic pairing of heavy/light chains.

Jiang Zhu1, Gilad Ofek, Yongping Yang, Baoshan Zhang, Mark K Louder, Gabriel Lu, Krisha McKee, Marie Pancera, Jeff Skinner, Zhenhai Zhang, Robert Parks, Joshua Eudailey, Krissey E Lloyd, Julie Blinn, S Munir Alam, Barton F Haynes, Melissa Simek, Dennis R Burton, Wayne C Koff, James C Mullikin, John R Mascola, Lawrence Shapiro, Peter D Kwong.   

Abstract

Next-generation sequencing of antibody transcripts from HIV-1-infected individuals with broadly neutralizing antibodies could provide an efficient means for identifying somatic variants and characterizing their lineages. Here, we used 454 pyrosequencing and identity/divergence grid sampling to analyze heavy- and light-chain sequences from donor N152, the source of the broadly neutralizing antibody 10E8. We identified variants with up to 28% difference in amino acid sequence. Heavy- and light-chain phylogenetic trees of identified 10E8 variants displayed similar architectures, and 10E8 variants reconstituted from matched and unmatched phylogenetic branches displayed significantly lower autoreactivity when matched. To test the generality of phylogenetic pairing, we analyzed donor International AIDS Vaccine Initiative 84, the source of antibodies PGT141-145. Heavy- and light-chain phylogenetic trees of PGT141-145 somatic variants also displayed remarkably similar architectures; in this case, branch pairings could be anchored by known PGT141-145 antibodies. Altogether, our findings suggest that phylogenetic matching of heavy and light chains can provide a means to approximate natural pairings.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23536288      PMCID: PMC3631616          DOI: 10.1073/pnas.1219320110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  A proteomics approach for the identification and cloning of monoclonal antibodies from serum.

Authors:  Wan Cheung Cheung; Sean A Beausoleil; Xiaowu Zhang; Shuji Sato; Sandra M Schieferl; James S Wieler; Jason G Beaudet; Ravi K Ramenani; Lana Popova; Michael J Comb; John Rush; Roberto D Polakiewicz
Journal:  Nat Biotechnol       Date:  2012-03-25       Impact factor: 54.908

2.  A short segment of the HIV-1 gp120 V1/V2 region is a major determinant of resistance to V1/V2 neutralizing antibodies.

Authors:  Nicole A Doria-Rose; Ivelin Georgiev; Sijy O'Dell; Gwo-Yu Chuang; Ryan P Staupe; Jason S McLellan; Jason Gorman; Marie Pancera; Mattia Bonsignori; Barton F Haynes; Dennis R Burton; Wayne C Koff; Peter D Kwong; John R Mascola
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

3.  Sequencing antibody repertoires: the next generation.

Authors:  Nicolas Fischer
Journal:  MAbs       Date:  2011-01-01       Impact factor: 5.857

4.  Broad HIV-1 neutralization mediated by CD4-binding site antibodies.

Authors:  Yuxing Li; Stephen A Migueles; Brent Welcher; Krisha Svehla; Adhuna Phogat; Mark K Louder; Xueling Wu; George M Shaw; Mark Connors; Richard T Wyatt; John R Mascola
Journal:  Nat Med       Date:  2007-08-26       Impact factor: 53.440

5.  Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1.

Authors:  Xueling Wu; Zhi-Yong Yang; Yuxing Li; Carl-Magnus Hogerkorp; William R Schief; Michael S Seaman; Tongqing Zhou; Stephen D Schmidt; Lan Wu; Ling Xu; Nancy S Longo; Krisha McKee; Sijy O'Dell; Mark K Louder; Diane L Wycuff; Yu Feng; Martha Nason; Nicole Doria-Rose; Mark Connors; Peter D Kwong; Mario Roederer; Richard T Wyatt; Gary J Nabel; John R Mascola
Journal:  Science       Date:  2010-07-08       Impact factor: 47.728

Review 6.  Human antibodies that neutralize HIV-1: identification, structures, and B cell ontogenies.

Authors:  Peter D Kwong; John R Mascola
Journal:  Immunity       Date:  2012-09-21       Impact factor: 31.745

7.  Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals.

Authors:  Johannes F Scheid; Hugo Mouquet; Niklas Feldhahn; Michael S Seaman; Klara Velinzon; John Pietzsch; Rene G Ott; Robert M Anthony; Henry Zebroski; Arlene Hurley; Adhuna Phogat; Bimal Chakrabarti; Yuxing Li; Mark Connors; Florencia Pereyra; Bruce D Walker; Hedda Wardemann; David Ho; Richard T Wyatt; John R Mascola; Jeffrey V Ravetch; Michel C Nussenzweig
Journal:  Nature       Date:  2009-03-15       Impact factor: 49.962

8.  High-throughput sequencing of the zebrafish antibody repertoire.

Authors:  Joshua A Weinstein; Ning Jiang; Richard A White; Daniel S Fisher; Stephen R Quake
Journal:  Science       Date:  2009-05-08       Impact factor: 47.728

9.  Relationship between anti-cardiolipin and anti-endothelial cell antibodies in systemic lupus erythematosus.

Authors:  A Vismara; P L Meroni; A Tincani; E N Harris; W Barcellini; A Brucato; M Khamashta; G R Hughes; C Zanussi; G Balestrieri
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

10.  Broad neutralization coverage of HIV by multiple highly potent antibodies.

Authors:  Laura M Walker; Michael Huber; Katie J Doores; Emilia Falkowska; Robert Pejchal; Jean-Philippe Julien; Sheng-Kai Wang; Alejandra Ramos; Po-Ying Chan-Hui; Matthew Moyle; Jennifer L Mitcham; Phillip W Hammond; Ole A Olsen; Pham Phung; Steven Fling; Chi-Huey Wong; Sanjay Phogat; Terri Wrin; Melissa D Simek; Wayne C Koff; Ian A Wilson; Dennis R Burton; Pascal Poignard
Journal:  Nature       Date:  2011-09-22       Impact factor: 49.962

View more
  82 in total

1.  Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 Loop.

Authors:  Shilpa Patil; Rajesh Kumar; Suprit Deshpande; Sweety Samal; Tripti Shrivastava; Saikat Boliar; Manish Bansal; Nakul Kumar Chaudhary; Aylur K Srikrishnan; Kailapuri G Murugavel; Suniti Solomon; Melissa Simek; Wayne C Koff; Rajat Goyal; Bimal K Chakrabarti; Jayanta Bhattacharya
Journal:  J Virol       Date:  2016-01-13       Impact factor: 5.103

Review 2.  Computational tools for epitope vaccine design and evaluation.

Authors:  Linling He; Jiang Zhu
Journal:  Curr Opin Virol       Date:  2015-03-31       Impact factor: 7.090

3.  Engineering HIV-Resistant, Anti-HIV Chimeric Antigen Receptor T Cells.

Authors:  Malika Hale; Taylor Mesojednik; Guillermo S Romano Ibarra; Jaya Sahni; Alison Bernard; Karen Sommer; Andrew M Scharenberg; David J Rawlings; Thor A Wagner
Journal:  Mol Ther       Date:  2017-01-28       Impact factor: 11.454

4.  De novo identification of VRC01 class HIV-1-neutralizing antibodies by next-generation sequencing of B-cell transcripts.

Authors:  Jiang Zhu; Xueling Wu; Baoshan Zhang; Krisha McKee; Sijy O'Dell; Cinque Soto; Tongqing Zhou; Joseph P Casazza; James C Mullikin; Peter D Kwong; John R Mascola; Lawrence Shapiro
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-08       Impact factor: 11.205

Review 5.  The high cost of fidelity.

Authors:  Sarah B Lloyd; Stephen J Kent; Wendy R Winnall
Journal:  AIDS Res Hum Retroviruses       Date:  2014-01       Impact factor: 2.205

6.  Optimization of the Solubility of HIV-1-Neutralizing Antibody 10E8 through Somatic Variation and Structure-Based Design.

Authors:  Young D Kwon; Ivelin S Georgiev; Gilad Ofek; Baoshan Zhang; Mangaiarkarasi Asokan; Robert T Bailer; Amy Bao; William Caruso; Xuejun Chen; Misook Choe; Aliaksandr Druz; Sung-Youl Ko; Mark K Louder; Krisha McKee; Sijy O'Dell; Amarendra Pegu; Rebecca S Rudicell; Wei Shi; Keyun Wang; Yongping Yang; Mandy Alger; Michael F Bender; Kevin Carlton; Jonathan W Cooper; Julie Blinn; Joshua Eudailey; Krissey Lloyd; Robert Parks; S Munir Alam; Barton F Haynes; Neal N Padte; Jian Yu; David D Ho; Jinghe Huang; Mark Connors; Richard M Schwartz; John R Mascola; Peter D Kwong
Journal:  J Virol       Date:  2016-06-10       Impact factor: 5.103

7.  Selection of therapeutic H5N1 monoclonal antibodies following IgVH repertoire analysis in mice.

Authors:  Sean A Gray; Margaret Moore; Emily J VandenEkart; Richard P Roque; Richard A Bowen; Neal Van Hoeven; Steven R Wiley; Christopher H Clegg
Journal:  Antiviral Res       Date:  2016-04-21       Impact factor: 5.970

8.  Recombinant HIV envelope trimer selects for quaternary-dependent antibodies targeting the trimer apex.

Authors:  Devin Sok; Marit J van Gils; Matthias Pauthner; Jean-Philippe Julien; Karen L Saye-Francisco; Jessica Hsueh; Bryan Briney; Jeong Hyun Lee; Khoa M Le; Peter S Lee; Yuanzi Hua; Michael S Seaman; John P Moore; Andrew B Ward; Ian A Wilson; Rogier W Sanders; Dennis R Burton
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-24       Impact factor: 11.205

9.  Long Single-Molecule Reads Can Resolve the Complexity of the Influenza Virus Composed of Rare, Closely Related Mutant Variants.

Authors:  Alexander Artyomenko; Nicholas C Wu; Serghei Mangul; Eleazar Eskin; Ren Sun; Alex Zelikovsky
Journal:  J Comput Biol       Date:  2016-11-30       Impact factor: 1.479

Review 10.  HIV broadly neutralizing antibody targets.

Authors:  Constantinos Kurt Wibmer; Penny L Moore; Lynn Morris
Journal:  Curr Opin HIV AIDS       Date:  2015-05       Impact factor: 4.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.